| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 06/12/2001 | US6245326 Health supplement |
| 06/12/2001 | CA2171453C Glutathione analogs and paralog panels comprising glutathione mimics |
| 06/07/2001 | WO2001040500A1 Feeding assay for identifying nematicidal compounds |
| 06/07/2001 | WO2001040499A2 Methods for cell screening of compounds capable of modulating the activity of ubiquitin-ligase scf complexes and their uses |
| 06/07/2001 | WO2001040460A1 Screening method for compounds capable of modularing egr-1-regulated expression |
| 06/07/2001 | WO2001040457A1 Semaphorin receptor |
| 06/07/2001 | WO2001040456A1 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | WO2001040451A2 Masp-3, a complement-fixing enzyme, and uses for it |
| 06/07/2001 | WO2001040316A1 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block |
| 06/07/2001 | WO2001040309A2 Anti-prostate stem cell antigen (psca) antibody compositions and methods of use |
| 06/07/2001 | WO2001040303A1 Transcription factors containing two potential dna binding motifs |
| 06/07/2001 | WO2001040279A2 Hbv sequences |
| 06/07/2001 | WO2001040271A2 Cancer associated antigens and uses therefor |
| 06/07/2001 | WO2001040251A1 Transforming growth factor alpha hiii |
| 06/07/2001 | WO2001040231A1 Heterocyclic dihydropyrimidines as potassium channel inhibitors |
| 06/07/2001 | WO2001040218A1 Arylamine derivatives and their use as anti-telomerase agent |
| 06/07/2001 | WO2001040217A1 Novel benzoimidazole derivatives useful as antiproliferative agents |
| 06/07/2001 | WO2001040215A1 2,4-diaminopyrimidine compounds usful as immunosuppressants |
| 06/07/2001 | WO2001040201A1 Oxazolidinone derivatives |
| 06/07/2001 | WO2001039822A1 Device for injection of antiparasitic agents in pets |
| 06/07/2001 | WO2001039805A1 Concomitant drugs for treating glaucoma |
| 06/07/2001 | WO2001039788A2 Methods for targeting cells that express fibroblast growth receptor-3 or-2 |
| 06/07/2001 | WO2001039784A1 Pancreatic stem cells and their use in transplantation |
| 06/07/2001 | WO2001039781A1 Pharmaceutical combinations |
| 06/07/2001 | WO2001039779A1 A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders |
| 06/07/2001 | WO2001039777A1 Compounds specific to adenosine a1 a2a, and a3 receptors and uses thereof |
| 06/07/2001 | WO2001039775A1 Benzimidazole compounds having nociceptin receptor affinity |
| 06/07/2001 | WO2001039767A1 Tertiary amino compounds having opioid receptor affinity |
| 06/07/2001 | WO2001039765A2 Compositions and methods for the induction and treatment of retinal detachments |
| 06/07/2001 | WO2001039763A2 Use of methylol-containing compounds for the manufacture of a medicament for the treatment of tumors |
| 06/07/2001 | WO2001039762A2 Use of taurolidine or taurultam for the manufacture of a medicament for the treatment of tumors of the central nervous system |
| 06/07/2001 | WO2001039761A1 Administration of an alpha-2 adrenergic receptor agonist to enhance cardiopulmonary resuscitation |
| 06/07/2001 | WO2001039759A2 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds |
| 06/07/2001 | WO2001039750A1 Effervescent histamine h2 antagonist composition |
| 06/07/2001 | WO2001039744A2 Radiation sensitive liposomes |
| 06/07/2001 | WO2001007612A3 Receptors and associated proteins |
| 06/07/2001 | WO2000072823A8 Preparations for the application of anti-inflammatory agents |
| 06/07/2001 | WO2000069424A3 Method of treating psychotic disorders |
| 06/07/2001 | WO2000032752A9 Psca: prostate stem cell antigen and uses thereof |
| 06/07/2001 | US20010002999 For oral administration comprising an analgesic with rapid onset of action and at least one systemically acting analgesic with sustained action, such as a combination of benzocaine and acetylsalicylic acid (ASA) |
| 06/07/2001 | DE19958153A1 Oxazolidinon-Derivate Oxazolidinone derivatives |
| 06/07/2001 | DE19957898A1 Treatment of legionnaire's disease using pulmonary surfactant preparation, preventing acute lung injury or adult respiratory distress syndrome without risk of development of resistance |
| 06/07/2001 | DE19955607A1 Medikament oder aufeinander abgestimmte Kombination von Medikamenten Drug or combination of drugs concerted |
| 06/07/2001 | DE19955576A1 Transferverbindungen, ihre Herstellung und ihre Verwendung Transfer compounds, their preparation and their use |
| 06/07/2001 | CA2696185A1 Use of taurolidine and derivatives thereof in the treatment of cancer by induction of apoptosis |
| 06/07/2001 | CA2398927A1 Administration of an alpha-2 adrenergic receptor agonist to enhance cardiopulmonary resuscitation |
| 06/07/2001 | CA2394996A1 Transcription factors containing two potential dna binding motifs |
| 06/07/2001 | CA2393252A1 Use of methylol-containing compounds to treat tumors |
| 06/07/2001 | CA2393217A1 Oxazolidinone derivatives |
| 06/07/2001 | CA2393179A1 Compounds specific to adenosine a1 a2a, and a3 receptors and uses thereof |
| 06/07/2001 | CA2393115A1 Methods for cell screening of compounds capable of modulating the activity of ubiquitin-ligase scf complexes and their uses |
| 06/07/2001 | CA2392991A1 Semaphorin receptor |
| 06/07/2001 | CA2392853A1 Hbv sequences |
| 06/07/2001 | CA2392717A1 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | CA2392615A1 Pancreatic stem cells and their use in transplantation |
| 06/07/2001 | CA2392540A1 Feeding assay for identifying nematicidal compounds |
| 06/07/2001 | CA2392507A1 Arylamine derivatives and their use as anti-telomerase agent |
| 06/07/2001 | CA2391402A1 Masp-3, a complement-fixing enzyme, and uses for it |
| 06/07/2001 | CA2390839A1 Transforming growth factor alpha hiii |
| 06/07/2001 | CA2390786A1 Compositions and methods for the treatment of immune related diseases |
| 06/07/2001 | CA2387108A1 Anti-prostate stem cell antigen (psca) antibody compositions and methods of use |
| 06/07/2001 | CA2327638A1 Combination of aldose reductase inhibitors and selective serotonin reuptake inhibitors for the treatment of diabetic complications |
| 06/07/2001 | CA2327575A1 Combination of aldose reductase inhibitors and antihypertensive agents for the treatment of diabetic complications |
| 06/06/2001 | EP1104683A1 Device for the injection of antiparasitic agents into pet animals |
| 06/06/2001 | EP1104483A1 Molecular cloning of a 7tm receptor (gpr31a) |
| 06/06/2001 | EP1104475A1 C-myc is activated by beta-catenin and tcf-4 |
| 06/06/2001 | EP1104473A2 Proteases and associated proteins |
| 06/06/2001 | EP1104465A1 14400 receptor, a g-protein coupled receptor |
| 06/06/2001 | EP1104464A2 Nucleic acids encoding a functional human purinoreceptor p2x2 and methods of producing and use thereof |
| 06/06/2001 | EP1104461A1 Grip, human adapter protein related to the grb2 family member |
| 06/06/2001 | EP1104440A1 A g-protein coupled 7tm receptor (axor-1) |
| 06/06/2001 | EP1104422A1 Phenyl xanthine derivatives |
| 06/06/2001 | EP1104421A1 3-(4-amino-5-ethylpyrimidine-2-yl)-1-(2-fluorobenzyl)-1h-pyrazolo 3,4-b]pyridine |
| 06/06/2001 | EP1104410A1 New carboxylic acid derivatives carrying keto side-chains, their production and their use as endothelin-receptor antagonists |
| 06/06/2001 | EP1104408A2 Drug targeting |
| 06/06/2001 | EP1104307A2 Pharmaceutical composition having inhibitory effect on overproduction and accumulation of extracellular matrix |
| 06/06/2001 | EP1104299A2 N-linked urea or carbamate of heterocyclic thioesters for vision and memory disorders |
| 06/06/2001 | EP1104296A1 Bioimplant formulation |
| 06/06/2001 | EP1104294A1 Compositions and methods of treating abnormal cell proliferation |
| 06/06/2001 | EP1104293A1 Regulation of substrate activity |
| 06/06/2001 | EP1104292A2 Treatment of vasodilatory headache |
| 06/06/2001 | EP1104289A2 New oral formulation for 5-ht4 agonists or antagonists |
| 06/06/2001 | EP0883695B1 Method and composition for hair removal |
| 06/06/2001 | EP0579626B1 Method and agents for promoting wound healing |
| 06/06/2001 | EP0536299B1 Surface complexed lymphotoxin |
| 06/06/2001 | CN1298451A Adenoviral vectors for treating disease |
| 06/06/2001 | CN1298445A Neuropilin antisense oligonucleotide sequences and methods of using same to modulate cell growth |
| 06/06/2001 | CN1298444A Insulin-like growth factor II antisense oligonucleotide sequences and methods of using same to modulate cell growth |
| 06/06/2001 | CN1298412A G-CSF receptor agonist antibodies and screening method therefor |
| 06/06/2001 | CN1298411A Caspase-8 interacting proteins |
| 06/06/2001 | CN1298309A Method for treating painful conditions of the anal region and compositions therefor |
| 06/06/2001 | CN1298308A Inhibitors of complement activation |
| 06/05/2001 | US6242488 Method for preventing and treating pain |
| 06/05/2001 | US6242479 Use of γ-tocopherol and its oxidative metabolite LLU-α in the treatment of disease |
| 06/05/2001 | US6242473 Administering histamine |
| 06/05/2001 | US6242469 Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| 06/05/2001 | US6242462 Novel decahydroisoquinoline derivatives which are selective glur5 receptor antagonists. |
| 06/05/2001 | US6242461 Use of aryl substituted azabenzimidazoles in the treatment of HIV and AIDS related diseases |
| 06/05/2001 | US6242447 Surgical irrigation solution and method for inhibition of pain and inflammation |
| 06/05/2001 | US6242446 Method for treating attention deficit disorder |